Pelthos Therapeutics Inc.
AMEX:PTHSBiotechnology
-$0.37 today
- Market cap
- $63.32M
- Beta
- 3.13
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$15.58
Volume 0.01M
Average 0.04M
PTHS Other Current Assets
Current assets not reported separately, such as prepaid expenses.
Pelthos Therapeutics Inc.AMEX: PTHS
Other Current Assets · Q1 FY2026 · quarter ended Mar 2026
Other current assets falls 24.6% from a year ago
Other current assets stood at $545K at the end of Q1 FY2026, down 24.6% from a year earlier and up 30.1% from the prior quarter.
Context
- Other current assets amounted to 0.4% of total assets at the end of Q1 FY2026, down 79.0 pp from a year earlier.
- Other current assets increased in 1 of the last 3 fiscal years.
What to watch
Whether other current assets keeps falling in the next quarterly balance sheet after a -24.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 419K USD
- Year-over-year change
- -44.1%
| Period | Period end | Other Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 419K | -44.1% |
| FY2024 | 2024-12-31 | 750K | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Other Current Assets vs competitors
How PTHS compares with its peers on the latest reported figures
- PTHS's Mar 2026 other current assets of $545K is the 3rd highest of the 4 companies compared; the peer median is $1.94M.
- Its year-over-year change of -24.6% is the lowest of 3, against a peer median of +437687.8%.
- Other current assets amounts to 0.4% of total assets for PTHS, versus a peer median of 6.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $1.73B | +875265.7% | — | 74.5% | |
| Mar 2026 | $1.94M | +109.9% | -63.5% | 6.3% | |
| Mar 2026 | $545K | -24.6% | — | 0.4% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding PTHS) | $1.94M | +437687.8% | -63.5% | 6.3% | |
Competitors are the stored peer set for PTHS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Pelthos Therapeutics Inc.
AMEX:PTHS
Intrinsic Alpha fair value
Locked
Current Price
$16.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.